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Copyright © 2009 JCBN Summary Vascular complications, as a consequence of atherosclerosis, are main causes of
morbidity and mortality in patients with diabetes mellitus. There is increasing evidence that
lipid peroxidation and oxidative modification of low density lipoprotein (LDL) is important in
atherogenesis. In this study we investigated the effect of soybean hypocotyl extract (SHE), rich
in isoflavones and saponins, on lipid peroxide (LPO) levels in liver, plasma and lipoproteins in
GK diabetic rats, and its efficacy on the reduction of susceptibility of LDL and high density
lipoprotein (HDL) to oxidation. The oxidative modification of LDL and HDL was determined
with the lag time of copper ion-induced oxidation curve identified by the conjugated dienes.
In SHE group which were fed diet containing 40 g/kg of SHE for 16 weeks, LPO levels in liver,
plasma and HDL fraction were significantly decreased compared with the control group. The
lag phage of LDL oxidation curve was prolonged noticeably by a mean of 27 min in SHE
group as compared to the control group, indicating a reduced susceptibility to oxidation. The
results suggest that intake of soybean hypocotyl extract might be useful for the prevention and
treatment of diabetes mellitus and diabetes-associated diseases.
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Introduction
Soybeans contain valuable nutritional attributes. It has
been found that the intake of soy foods is closely related to
lowering the occurrences of chronic diseases [1–5]. There
are many functional ingredients contained in soy foods such
as soy protein, isoflavones, saponins, phytic acid, phytosterol,
and phenolic acid [2]. Among them, isoflavones and saponins
are most commonly noted, and the both seem to be concen-
trated in the soybean hypocotyl. Soyasaponins have drawn
interest in recent years due to their potential multiple health-
promoting properties including plasma cholesterol lowering
[3], anticarcinogenic [4, 5], hepatoprotective [6], and anti-
viral activities [7]. Recent reports demonstrated that the in
vivo reduction in hepatic lipid peroxidation in mice intra-
peritoneally injected with soyasaponins was comparable to
that which has been observed for α-tocopherol, and the
effects of soyasaponins on lipid peroxidation levels appear
to be mediated through the secretion of thyroid hormones
[8]. Soy primarily contains 3 types of isoflavone glycosides:
genistin, daidzin, and glycitin. The isoflavone aglycones,
genistein, daidzein, and glycitein, are structurally related to
17-estradiol, hence, they are often referred to as phyto-
estrogens [9]. Kerry and Abbey reported that genistein
inhibits copper- and peroxy radical–mediated low density
lipoprotein (LDL) oxidation when added to a cell-free
oxidation system but not when incorporated into LDLAnti-oxidative Effect of Soy Hypocotyl in GK Rats
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particles before the oxidation reaction [10]. Kapiotis et al.
also reported that genistein, but not daidzein, inhibits
copper-mediated LDL oxidation, as shown by the inhibition
of thiobarbituric acid–reactive substances (TBARS) and the
formation of hydroperoxides in cell-free systems [11]. In
contrast with in vitro studies, data from interventional
studies have failed to show an antioxidant effect from
isoflavone supplements [12–14]. Several studies have
suggested that soy intake aids against oxidative stress, as
indicated on the basis of measurements of conjugated dienes
in the LDL fraction [15, 16], lag time for copper-induced
LDL oxidation [17, 18], and plasma concentrations of F2-
isoprostanes [17]. However, results from other studies failed
to support the antioxidant effects of soy [19,  20]. The
potential decrease in oxidative stress has been ascribed to
the isoflavone component of the soybeans. Soybeans and
products derived from soybeans represent the major source
of dietary isoflavones [21]. Compared with the major anti-
oxidants in plasma (ascorbic acid, uric acid, α-tocopherol,
β-carotene, and other carotenoids) [22, 23], the concentra-
tion of isoflavones in plasma is relatively low and can reach
concentrations comparable with those of carotenoids, only
after the consumption of meals containing soy products high
in isoflavones or isoflavone supplements [17,  24]. One
possibility for the discordant observations to date is that
there is a potential independent effect of soy isoflavones, or
the synergistic effect of isoflavones and other soy-derived
phytochemicals. This possibility has not been adequately
addressed. Therefore, the aim of this study was to evaluate
the anti-oxidative effect of soy hypocotyl, rich in soyasa-
ponins and isoflavones in GK diabetic rats in order to clarify
the paradox.
Materials and Methods
Reagents and chemicals
Cholesterol (CH), phospholipid (PL) and triglyceride
(TG) kits and Glucose B Test kit were purchased from Wako
Pure Chemical Industries Ltd. (Osaka, Japan). Lipid peroxide
(LPO) test kit was obtained from Kyowa Medex Company
Ltd. (Tokyo, Japan). Malondialdehyde (MDA) test kit was
obtained from the Nanjing Jiancheng Bioengineering Insti-
tute (Nanjing, China). Daidzein, daidzin, malonyldaidzin,
glycitein, glycitin, malonylglycitin and malonylgenistin
were purchased from Fujicco Company Ltd. (Kobe, Japan).
Genistein and genistin were obtained from Extrasynthese
(Genay, France).
Preparation and characterization of test extract
Soybean seeds (Glycine max (L.) Merrill) were obtained
from the National Institute of Agrobiological Resources of
Japan. Soybean hypocotyl was shaken with 50% ethanol
overnight and the solution was filtered. The filtrate was
spray-dried; the powder was then dissolved in 10% ethanol
and applied to ODS column (YMC, ODS-A60-S150,
5c m× 74 cm). The column was then eluted step-wisely
with 10%, 30%, 50%, 80% and 100% ethanol. Each fraction
was collected, evaporated to dryness under vacuum, and
finally lyophilized. Fractions were analyzed with thin
layer chromatography (TLC) and high-performance liquid
chromatography (HPLC) before further application. The
10% fraction consisted of soybean oligosaccharides; 30%,
50% and 80% fractions consisted of soybean isoflavones
and soyasaponins. Therefore, soybean hypocotyl extract
(SHE) was the mixture of 30%, 50% and 80% fractions in
this experiment. The composition of SHE was as follows
(mg/g). Isoflavone: malonyldaidzin 63.2, malonylglycitin
27.5, malonylgenistin 19.1, daidzin 29.3, glycitin 10.4,
genistin 6.3, daidzein 12.7, glycitein 3.6, genistein 2.9;
saponin: Aa 147.9, Ae 316.4, Ba 20.3, Bb 81.5, Bd 15.7, Be
30.3, αg 21.9, βg 73.8.
To guarantee reproducibility of pharmacological experi-
ments, isoflavone and saponin contents of fractions and SHE
were analyzed with TLC and HPLC before further applica-
tion. For analysis of isoflavones and saponins, each fraction
was dissolved in methanol and filtered through a 0.45 μm
filter (Millipore). TLC was performed on silica gel (Merck,
Kieselgel 60 F-254) with a lower phase of chloroform-
methanol-water (65:35:10, v/v). Spots were visualized first
by UV-monitoring at 210 nm for saponins and 260 nm for
isoflavones, then by heating at 120°C for 10 min after
spraying with 10% sulfuric acid. HPLC was carried out as
follows. HPLC instrument: Waters 600E system; column:
YMC-packed ODS-AM-303 column (5 μm, 4.6 mm × 50
mm); flow rate: 1.0 ml/min; UV-detection: absorption at
210 nm and 260 nm for saponins and isoflavones, respec-
tively; mobile phase: 40% acetonitrile containing 1%
trifluoroacetic acid for the detection of saponins, a linear
gradient of acetonitrile from 15% to 35% containing 1%
trifluoroacetic acid for the detection of isoflavones.
Experimental animals
Six-week-old male GK/Jcl type 2 diabetic rats with a
mean weight of approximately 92 g were purchased from
Japan Clea Inc. Twenty GK rats were randomly assigned to
two groups: the control and SHE group. The control group
was fed on a standard laboratory chow; while SHE group
was fed a standard diet containing 40 g/kg of SHE for 16
weeks. The composition of the control diet was as follows
(g/kg). Casein 250, corn starch 300, sucrose 250, cellulose
powder 50, corn oil 100, mineral mixture 35, vitamin
mixture 10, methionine 3, choline bitartrate 2. The composi-
tion of the mineral mixture was according to AIN-93G MX
and that of the vitamin mixture to AIN-93G VX [25]. SHE
was added to the diet at the expense of starch. Experimental
animals were housed in an air-conditioned room at 25°C,J. Quan et al.
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under a natural light-dark regimen. Rats were allowed free
access to powdered feed and water that was supplied
through an automatic watering system ad libitum. All
experiment was carried out in accordance with the recom-
mendations of the Institutional Animal Care and Use of
Committee of Yanbian University.
Determination of MDA in liver homogenate
At the end of the experimental period, rats were sacrificed
and the liver was excised, rinsed with chilled 0.2 M
phosphate buffer (pH 7.2). The liver (1 g) were homo-
genized in 0.2 M phosphate buffer saline (pH 7.2) in an ice
bath and the homogenate was centrifuged at 145 × g for
10 min at 4°C. The supernatant was used for assay of MDA
with the thiobarbituric acid method with the MDA test kit.
Determination of blood biochemical parameters
The blood sample were collected in the test tube containing
EDTA after an overnight fast at the beginning and at the end
of the 16-week period, and plasma was immediately
separated by centrifugation at 1000 × g for 15 min at 4°C.
Blood lipids and glucose and other parameters were detected
with a biochemical autoanalyser (Hitachi 736-15, HITACHI,
Japan) with respective commercial test kits. LPO were
determined enzymatically, using a kit according to the manu-
facturer’s instruction. MDA content, a degrading product of
lipid peroxidation known as thiobarbituric acid–reactive
substances (TBARS), was determined according to the
thiobarbituric acid method using a MDA test kit.
Preparation of lipoproteins and determination of lipid
The very low density lipoprotein (VLDL), low density
lipoprotein(LDL), high density lipoprotein (HDL) were
isolated by sequential ultracentrifugation by a modified
method of Havel et al. [26] in a HITACHI himac cpα 100
ultracentrifuge. Following ultracentrifugation of HDL, the
bottom fraction was taken to represent very high density
faction with a density greater than 1.21 (VHDL, also called
lipoprotein-deficient fraction). TG, CH and LPO levels in
lipoprotein were determined by enzymatic methods using
commercial test kits; protein was measured according to the
modified Lowry procedure of Markwell et al. [27]. All the
data were normalized for the original volume of blood
plasma.
Copper ion-mediated oxidation of LDL and HDL
The isolated LDL and HDL were incubated with pH 7.4,
10 mM PBS buffer for a total of 20 h at 4°C. Following
dialysis, the protein concentration in lipoprotein fractions
was determined by the modified Lowry procedure of
Markwell et al. [27] and adjusted to 0.1 g/L. LDL and HDL
oxidation was stimulated by the addition of copper sulfate in
PBS to produce a final copper ion concentration of 5 μM.
The formation of conjugated dienes (CD) was continuously
monitored in a Shimadzu UV-1202 spectrophotometer at
234 nm over a period of 3 h. The indices of lipid peroxida-
tion measured were lag time and oxidation rate. The length
of the lag phase was defined as the lag time to the intercept
of the tangent of the absorbance curve in the propagation
phase with baseline. Propagation rate was expressed as the
slope of the tangent (change in absorbance/min) [10, 28].
Statistical analysis
All the results were presented as mean ± SD. Student’s t
test was performed using SPSS 10.0 software. Differences
were considered statistically significant when p<0.05.
Results
Table 1 shows the levels of body weight (BW), blood
glucose (BG), TG, CH and HDL-C at the beginning (0 week)
and at the end of the experimental period (16 week). During
the feeding period, BG levels and body weights increased
and TG decreased in each group of all the rats. However, no
differences in body weights and TG levels were observed in
this experiment, when comparing SHE group with the
control group. No changes were observed in the levels of
total cholesterol or HDL-cholesterol in this experiment,
either. At the end of the feeding period, BG levels of rats
fed with SHE were significantly lower than those of control
animals (Table 1).
In this experiment, the lipid peroxidation was studied as
an index of oxidative damage. An elevated level of lipid
peroxides was observed in the plasma of diabetic rats during
the experiment. Results show that chronic SHE administra-
tion significantly decreased blood LPO and MDA levels of
SHE group as compared to the control group (Table 1).
Other biochemical parameters, including total protein
(TP), total bilirubin (T-BIL), blood urea nitrogen (BUN),
Table 1. Effect of SHE on body weight, blood glucose, blood lipids, LPO and MDA levels of GK rats
The results are expressed as means ± SD of ten rats per group. *p<0.05, compared with control group.
Period (week) Group BW (g) BG (mM) TG (mg/dl) CH (mg/dl) HDL-C (mg/dl) LPO (µM) MDA (µM)
0 Control 91 ± 55 . 8 ± 0.9 31.9 ± 3.3 112 ± 21 81.2 ± 11.9 7.0 ± 1.3 5.2 ± 2.1
SHE 92 ± 55 . 8 ± 1.0 32.2 ± 3.2 112 ± 17 81.1 ± 12.0 7.1 ± 0.7 5.4 ± 1.2
16 Control 357 ± 11 14.3 ± 1.3 17.9 ± 3.1 107 ± 23 78.2 ± 14.3 11.2 ± 2.2 7.9 ± 2.4
SHE 364 ± 13 11.4 ± 0.9* 18.2 ± 3.5 109 ± 17 82.1 ± 11.9 8.1 ± 0.7* 5.9 ± 1.8*Anti-oxidative Effect of Soy Hypocotyl in GK Rats
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creatinine (Cr), uric acid (UA), glutamate oxaloacetate
transaminase (GOT) and glutamate pyruvate transaminase
(GPT) were not modified by SHE treatment (Table 2).
The hepatic lipid peroxidation in terms of thiobarbituric
acid-reactive substances was also measured as an index of
oxidative damage to liver. Results show that the hepatic
MDA level of SHE group [(3.2 ± 1.1) μmol/g protein] was
significantly lower than that of control group [(4.9 ± 1.4)
μmol/g protein]. Results confirm that SHE participates in
the prevention of oxidative damage to both the plasma and
liver.
Lipid peroxidation (LPO) was also studied in lipoprotein
fractions at the end of the experiment. Results show that 16
weeks of SHE feeding significantly decreased HDL-LPO
(Table 3). The chronic SHE administration slightly decreased
the LPO status of LDL, but the differences between the two
groups were not significant (p = 0.12, Table 3). No differ-
ences in TG, CH, PL, and protein levels of lipoprotein
fractions were observed in this experiment, when comparing
SHE group with the control group (Data were not shown).
The isolated LDLs and HDLs were subjected to copper
ion-induced oxidation. The results indicated a significant
mean prolongation of the LDL lag phase by more than
27 min in SHE group as compared to control group after 16
weeks of SHE feeding (Table 4). The lag phase of HDL
oxidation curve also increased, but insignificantly. There
was also a significant decrease in the propagation rate of
LDL but the accumulated LDL and HDL conjugated dienes
were not significantly different between SHE and control
animals during the incubation period (Table 4). When the
lipid peroxide content in lipoprotein fractions was expressed
on a per cholesterol basis, then LDL and HDL of SHE group
were found to contain less LPO molecules at the beginning
of copper ion-induced oxidation than the control group
(p = 0.09 and 0.01 for LDL and HDL, respectively, Table 4).
Discussion
Over the last few years, research has focused on soybean
constituents such as isoflavones, phytosterols, saponins,
water- and fat-soluble vitamins, and minerals [29,  30].
Tanizawa et al. [31] reported that soyasaponins inhibit the in
vivo Adriamycin-induced increase of lipid peroxide levels in
the myocardium of mice and saponin constituents are also
responsible for a reduction of NADPH-induced lipid
peroxidation (in vitro) in mice hepatic microsomes. In a
small study, Tikkanen et al. [18] also documented that the
consumption of soy bars for 2 week resulted in a longer lag
phase of copper-induced LDL oxidation than that at base-
line. However, there is a contradiction about the in vivo
effect of isoflavones and saponins on lipid oxidation [12–
14]. It encourages us to investigate the in vivo antioxidant
properties of soy hypocotyl, rich in isoflavones and
saponins, in whole plasma and isolated lipoprotein fractions.
In this study isoflavones and saponins in soybean hypo-
Table 2. Effect of SHE on blood biochemical parameters of GK rats
The results are expressed as means ± SD of ten rats per group. †Probability (p) was calculated with Student’s t test using SPSS 10.0 soft-
ware.
Group TP (g/dl) T-BIL (mg/dl) GOT (U/l) GPT (U/l) UA (mg/dl) BUN (mg/dl) Cr (mg/dl)
Control 6.2 ± 0.3 0.0 ± 0.0 123 ± 17 120 ± 21 1.4 ± 0.7 14.4 ± 1.1 0.3 ± 0.0
SHE 6.3 ± 0.2 0.0 ± 0.1 127 ± 23 119 ± 25 1.5 ± 0.6 13.8 ± 1.7 0.3 ± 0.0
p value† 0.29 0.71 0.67 0.47 0.74 0.32 0.64
Table 3. Effect of SHE on LPO levels in lipoprotein fractions
The results are expressed as means ± SD of ten rats per group.
Data have been normalized for the original volume of blood plas-
ma. *p<0.05, compared with control group.
Group
LPO concentration in lipoprotein fractions (μM)
VLDL LDL HDL VHDL
Control 1.4 ± 0.4 2.7 ± 0.9 6.6 ± 1.6 0.3 ± 0.1
SHE 1.2 ± 0.3 2.2 ± 0.4 4.8 ± 1.2* 0.2 ± 0.1
Table 4. Change of susceptibility of LDL and HDL to oxidation
The results are expressed as means ± SD of six rats per group. †The initial hydroperoxide contents in lipoprotein fractions at the beginning
of oxidation were expressed on a per mg cholesterol basis. ‡ Absorbance units were converted to molar units of conjugated dienes (CD)
using the molar extinction coefficient 29500 M−1·cm−1. *p<0.05, compared with control group.
Group
Initial LPO† 
(nmol/mg cholesterol)
Lag time 
(min)
CD‡ 
(nmol/mg protein)
Propagation rate 
(ΔA234/min × 10−2)
LDL HDL LDL HDL LDL HDL LDL HDL
Control 9.5 ± 2.4 8.4 ± 1.7 38 ± 21 19 ± 10 95 ± 37 20 ± 93 . 5 ± 1.2 0.52 ± 0.22
SHE 8.1 ± 1.9 6.4 ± 2.0* 65 ± 29* 26 ± 12 89 ± 33 18 ± 10 3.1 ± 1.1* 0.49 ± 0.20J. Quan et al.
J. Clin. Biochem. Nutr.
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cotyl occur as glucose-conjugated forms. Once ingested,
these glucosides are hydrolyzed to absorbable aglycones
[32]. It is commonly assumed that isoflavone aglycones are
absorbed quickly compared with glucoside forms. However,
the bioavailability of aglycones and glucosides of soy
isoflavones is controversial [33,  34]. Soyasaponins may
have very low absorbability in the human gut. According to
the study of Hu et al. [35], soyasaponins are taken up by gut
epithelial cells in a saturable manner in small amounts; in
contrast, the uptake of soyasapogenol may depend upon its
concentration in the lumen. The absorbed soyasaponin or
sapogenol may also contribute to anticancer activity [35].
The most widely used methods for monitoring lipid
oxidation are the measurement of lipid peroxides, thiobar-
bituric acid reactive substance and conjugated diene levels.
In our study the addition of SHE to daily diet clearly reduced
the plasma and hepatic LPO levels. Moreover, LPO levels in
the isolated HDL samples from SHE group were signifi-
cantly lower than those from the control group. The result
indicates reduced lipid peroxidation of the liver, plasma and
high density lipoprotein fraction. The chronic SHE adminis-
tration also slightly decreased the LPO status of LDL, but
the differences between the two groups were not significant.
The result may be explained with the fact that HDL is the
principal vehicle for circulating plasma lipid hydroperoxides
and may be more rapidly oxidized than those in LDL in vivo
[36]. Lipid peroxides may accumulate more rapidly in HDL
than in LDL in vivo because of the antioxidant action of
CoQH2 in the LDL [31].
According to the study of Bowry et al. [36], even though
HDL particles carry most (≈85%) of the detectable oxidized
core lipoprotein lipids, LDL core lipids were oxidized more
rapidly after most ubiquinol-10 present in LDL was
consumed. Therefore, we have also examined the effect of
SHE on the susceptibility of LDL and HDL to oxidation. All
samples of SHE group showed similar shifts of the propaga-
tion curves to the right as compared to the control group. Our
finding that 16 weeks of SHE feeding caused a significant
prolongation of lag time of LDL is potentially important, as
oxidative modification of LDL is regarded as atherogenic.
The elevated concentrations of circulating antioxidant
phytochemicals such as isoflavones and saponins during
SHE feeding could have protected LDL from oxidation and
resulted in a reduction of the initiation rate. Even given a
significant reduction of HDL-LPO after SHE administra-
tion, there was no significant difference in the formation of
conjugated dienes and lag time of HDL oxidation between
the two groups. The much lower initiation rate and shorter
lag time of HDL oxidation curve may explain the “lack” of a
protective effect of SHE against HDL oxidizability in some
way.
In this experiment, antioxidant activity of SHE was
confirmed. In diabetic rats, the consumption of soybean
hypocotyl rich in isoflavones and saponins reduced the liver,
plasma and HDL lipid peroxidation and the oxidative modi-
fication of LDL. These findings suggest that soybean
hypocotyl, the natural combination of isoflavones and
saponins, might have a therapeutic value for the prevention
and treatment of diabetes-associated atherosclerosis.
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